This study aims to refine and pilot test PDAC-PATHWAYS, a digital informational and supportive care app for patients who are initiating neoadjuvant therapy for pancreatic ductal adenocarcinoma (PDAC).
Age≥18 years
Within 8 weeks of a documented decision to pursue neoadjuvant therapy for newly diagnosed, non-metastatic PDAC
Able to comprehend and speak English
Comorbid health condition that would interfere with study participation, as identified by the cancer care team
Massachusetts General Hospital
Lead sponsor
United States Department of Defense
Collaborator